NasdaqCM - Nasdaq Real Time Price USD

Benitec Biopharma Inc. (BNTC)

16.48
+0.56
+(3.52%)
At close: 4:00:00 PM EDT
16.48
0.00
(0.00%)
After hours: 4:04:04 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
0
0
75
73
59
Cost of Revenue
--
--
0
9
123
Gross Profit
--
--
75
64
-64
Operating Expense
30,029
22,490
19,156
17,918
13,532
Operating Income
-30,137
-22,490
-19,081
-17,854
-13,596
Net Non Operating Interest Income Expense
3,170
904
-33
-32
-6
Other Income Expense
477
-165
-448
-322
-280
Pretax Income
-26,490
-21,751
-19,562
-18,208
-13,882
Net Income Common Stockholders
-26,490
-22,370
-19,562
-18,208
-13,882
Diluted NI Available to Com Stockholders
-26,490
-22,370
-19,562
-18,208
-13,882
Basic EPS
-5.03
-5.51
-14.12
-37.91
-54.91
Diluted EPS
-5.03
-5.51
-14.12
-37.91
-54.91
Basic Average Shares
18,072.52
4,060.18
1,385.82
480.69
252.67
Diluted Average Shares
18,072.52
4,060.18
1,385.82
480.69
252.67
Total Operating Income as Reported
-30,137
-22,490
-19,081
-17,854
-13,596
Total Expenses
30,137
22,490
19,156
17,927
13,655
Net Income from Continuing & Discontinued Operation
-26,490
-21,751
-19,562
-18,208
-13,882
Normalized Income
-27,126
-21,790
-19,144
-17,965
-13,565
Interest Income
62
--
--
--
-6
Interest Expense
--
--
33
32
6
Net Interest Income
3,170
904
-33
-32
-6
EBIT
-30,137
-22,490
-19,081
-18,176
-13,876
EBITDA
-29,768
-22,147
-18,700
-17,784
-13,452
Reconciled Cost of Revenue
--
--
0
9
123
Reconciled Depreciation
369
343
381
392
424
Net Income from Continuing Operation Net Minority Interest
-26,490
-21,751
-19,562
-18,208
-13,882
Total Unusual Items Excluding Goodwill
636
39
-418
-243
-317
Total Unusual Items
636
39
-418
-243
-317
Normalized EBITDA
-30,404
-22,186
-18,282
-17,541
-13,135
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
6/30/2021 - 6/24/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SOFTX.OL SoftOx Solutions AS
0.0806
-3.82%
 
ARMP Armata Pharmaceuticals, Inc.
1.8700
-6.97%
 
ETNB 89bio, Inc.
10.41
+8.21%
 
MNPR Monopar Therapeutics Inc.
33.52
-0.89%
 
ACLX Arcellx, Inc.
66.00
-0.77%
 
NANECH.ST NanoEcho AB
0.0819
-3.53%
 
MOLNz.XC
 
BPTSY Biophytis S.A.
1.3800
0.00%
 
UPB Upstream Bio, Inc.
11.36
-1.73%
 
FHTX Foghorn Therapeutics Inc.
4.3200
-4.85%